KIF1A-associated neurological disorder: Year of the Zebra

Last updated: November 28, 2023

KIF1A-associated neurological disorder: Year of the Zebra

Watch later

Watch later

Chronic obstructive pulmonary disease (COPD): Nursing process (ADPIE)
Laryngotracheobronchitis (LTB) and croup: Nursing process (ADPIE)
Cellular structure and function
Cell membrane
Selective permeability of the cell membrane
Osmosis
Extracellular matrix
Cytoskeleton and intracellular motility
Cell-cell junctions
Endocytosis and exocytosis
Cell signaling pathways
Resting membrane potential
Cell cycle
Mitosis and meiosis
Nuclear structure
DNA structure
Transcription of DNA
Translation of mRNA
Urinary catheters and routine indwelling catheter care: Clinical skills notes
Sodium homeostasis
Potassium homeostasis
Phosphate, calcium and magnesium homeostasis
Glucocorticoids and mineralocorticoids: Nursing pharmacology
Alpha-1 adrenergic blockers: Nursing pharmacology
Alpha-2 adrenergic agonists: Nursing pharmacology
Angiotensin II receptor blockers (ARBs): Nursing pharmacology
Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology
Antiarrhythmics: Nursing pharmacology
Antihyperlipidemics - Fibrates: Nursing pharmacology
Antihyperlipidemics - Miscellaneous: Nursing pharmacology
Antihyperlipidemics - Statins: Nursing pharmacology
Beta-adrenergic blockers: Nursing pharmacology
Calcium-channel blockers: Nursing pharmacology
Cardiac glycosides: Nursing pharmacology
Direct-acting vasodilators: Nursing pharmacology
Nitrates: Nursing pharmacology
Sympathomimetic medications: Nursing pharmacology
Acid-base map and compensatory mechanisms
Announcing Year of the Zebra in 2023: Educating millions about rare disorders
The Year of the Zebra music video
Adrenal insufficiency: Year of the Zebra
Achalasia: Year of the Zebra
Esophageal atresia and tracheoesophageal fistula: Year of the Zebra
Esophageal cancer: Year of the Zebra
Hirschsprung disease: Year of the Zebra
Anemia of chronic disease: Year of the Zebra
Beta-thalassemia: Year of the Zebra
Hemophilia: Year of the Zebra
Pernicious anemia: Year of the Zebra
Autoimmune polyglandular syndrome type I (NORD): Year of the Zebra
Langerhans cell histiocytosis: Year of the Zebra
Epidermolysis bullosa: Year of the Zebra
Alagille syndrome (NORD): Year of the Zebra
Alkaptonuria: Year of the Zebra
Cornelia de Lange syndrome: Year of the Zebra
Fibromuscular dysplasia: Year of the Zebra
FOXG1 syndrome: Year of the Zebra
Gaucher disease (NORD): Year of the Zebra
Gorlin syndrome: Year of the Zebra
Leprosy: Year of the Zebra
Nail-patella syndrome: Year of the Zebra
PGAP3-congenital disorder of glycosylation: Year of the Zebra
PHACE syndrome: Year of the Zebra
Phenylketonuria (NORD): Year of the Zebra
Pierre Robin sequence: Year of the Zebra
Retroperitoneal fibrosis: Year of the Zebra
Sanfilippo syndrome: Year of the Zebra
Shwachman-Diamond syndrome: Year of the Zebra
Thoracic outlet syndrome: Year of the Zebra
Turner syndrome: Year of the Zebra
Ehlers-Danlos syndrome: Year of the Zebra
Facioscapulohumeral muscular dystrophy: Year of the Zebra
PIK3CA-related overgrowth spectrum (NORD): Year of the Zebra
Reiter syndrome: Year of the Zebra
Brown-Séquard syndrome: Year of the Zebra
Canavan disease: Year of the Zebra
Glioblastoma: Year of the Zebra
Huntington disease: Year of the Zebra
Idiopathic intracranial hypertension: Year of the Zebra
KIF1A-associated neurological disorder: Year of the Zebra
Narcolepsy (NORD): Year of the Zebra
Neuronal ceroid lipofuscinoses (Batten disease): Year of the Zebra
Syringomyelia: Year of the Zebra
Wernicke-Korsakoff syndrome: Year of the Zebra
Buerger disease: Year of the Zebra
Ovarian cancer: Year of the Zebra

Transcript

Watch video only

KIF1A-associated neurological disorder, or KAND for short, is a group of rare genetic conditions that result in progressive neurological dysfunction due to alterations in the KIF1A gene. The KIF1A gene codes for a specialized protein called kinesin found in neurons. Kinesin helps transport nutrients and other important molecules along the neuron’s axon, like a minecart on a railway track.

Alterations affecting the KIF1A gene lead to faulty kinesin that either stops or slows down axonal transport, resulting in neuronal dysfunction and even cell death.

So far, researchers have identified over 100 alterations affecting the KIF1A gene. These alterations can be inherited in autosomal dominant or recessive patterns, however, the most common and most severe forms are caused by de novo alterations, meaning they arise spontaneously and are not inherited.

Now, KAND is a spectrum-type condition, meaning the symptoms and progression vary greatly from one individual to another depending on the underlying gene alteration and pattern of inheritance.

One of the main features is spastic paraplegia, a condition where muscle weakness and stiffness in the legs causes the individual’s movements to jerk, affecting their ability to walk and move around.

Some children may also have a delay in reaching childhood milestones, like walking and talking, and they may experience difficulty with coordination and balance; as well as seizures and visual disturbances. Additionally, because brain development can be affected, individuals may have microcephaly, which is when head size is smaller than expected for an individual’s age.

Certain alterations in the KIF1A gene cause damage to sensory nerves, resulting in numbness and a tingling or burning sensation in the hands or feet. Less frequently, individuals may have dysfunction of the autonomic nerves that control involuntary bodily functions, like body temperature. As a result, individuals with KAND may have unexplained episodes of fever, which may be mistaken for having an infection.

Sources

  1. "Axonal transport and neurological disease. " Nat Rev Neurol (2019;15(12):691-703)
  2. "KIF1A variants are a frequent cause of autosomal dominant hereditary spastic paraplegia. " Eur J Hum Genet (2020;28(1):40-49)
  3. "Phenotypic expansion in KIF1A ‐related dominant disorders: A description of novel variants and review of published cases. " Hum Mutat (2020;41(12):2094-2104)
  4. "KIF1A-associated neurological disorder: An overview of a rare mutational disease. " Pharmaceuticals (Basel) (2023;16(2):147)